NCT06056791 Study of INKmune in Patients With mCRPC (CaRe Prostate) Status COMPLETED Phase PHASE1/PHASE2
NCT05933070 A Phase I Open-Label Dose Escalation Study of Intravenous INKmune In Patients With MDS or AML Status TERMINATED Phase PHASE1